10 گھنٹے - ترجمہ کریں۔

New Antibiotic for IBD Offers Targeted Treatment for Crohns Disease

Researchers have developed a targeted antibiotic for inflammatory bowel disease that could offer a new treatment for Crohns disease. The drug is called enterololin and was identified using artificial intelligence to accelerate drug discovery. It is designed to act directly in the gut while limiting effects on the rest of the body. Early work shows it can target harmful bacteria linked to inflammation without wiping out helpful microbes. The approach could reduce side effects compared with broad-spectrum antibiotics now used for gut conditions. Scientists say the AI system helped predict how the molecule works and why it stays focused in the intestine. More preclinical and clinical testing is needed to confirm safety and effectiveness in patients. If trials succeed the treatment could give doctors a more precise option for long-term IBD care.

image
advertisement
"We will never ask you to login, or register through a third-party advertisement."